nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Fluorouracil—colon cancer	0.153	0.259	CbGbCtD
Bupropion—CYP2B6—Irinotecan—colon cancer	0.104	0.175	CbGbCtD
Bupropion—CYP2C9—Capecitabine—colon cancer	0.0888	0.15	CbGbCtD
Bupropion—CYP2C8—Fluorouracil—colon cancer	0.0755	0.127	CbGbCtD
Bupropion—CYP1A2—Fluorouracil—colon cancer	0.0584	0.0987	CbGbCtD
Bupropion—CYP2C9—Fluorouracil—colon cancer	0.0527	0.0889	CbGbCtD
Bupropion—CYP3A4—Irinotecan—colon cancer	0.0319	0.0539	CbGbCtD
Bupropion—CYP3A4—Vincristine—colon cancer	0.0279	0.0471	CbGbCtD
Bupropion—ORM1—bile—colon cancer	0.0105	0.301	CbGeAlD
Bupropion—ORM1—gall bladder—colon cancer	0.00291	0.0835	CbGeAlD
Bupropion—CHRNA3—lymphoid tissue—colon cancer	0.00195	0.056	CbGeAlD
Bupropion—CYP2A6—vagina—colon cancer	0.00111	0.0319	CbGeAlD
Bupropion—CHRNA3—lymph node—colon cancer	0.0011	0.0316	CbGeAlD
Bupropion—ORM1—bone marrow—colon cancer	0.00106	0.0303	CbGeAlD
Bupropion—CYP2A6—liver—colon cancer	0.000936	0.0269	CbGeAlD
Bupropion—CYP2C8—renal system—colon cancer	0.00086	0.0247	CbGeAlD
Bupropion—ORM1—liver—colon cancer	0.000853	0.0245	CbGeAlD
Bupropion—CYP1A2—renal system—colon cancer	0.000805	0.0231	CbGeAlD
Bupropion—CYP2B6—renal system—colon cancer	0.000772	0.0221	CbGeAlD
Bupropion—CYP2E1—renal system—colon cancer	0.000724	0.0208	CbGeAlD
Bupropion—CYP1A2—digestive system—colon cancer	0.00066	0.019	CbGeAlD
Bupropion—ORM1—lymph node—colon cancer	0.000654	0.0188	CbGeAlD
Bupropion—CYP2B6—lymphoid tissue—colon cancer	0.000641	0.0184	CbGeAlD
Bupropion—CYP2B6—digestive system—colon cancer	0.000633	0.0182	CbGeAlD
Bupropion—CYP2C9—digestive system—colon cancer	0.000627	0.018	CbGeAlD
Bupropion—CYP2C8—vagina—colon cancer	0.000623	0.0179	CbGeAlD
Bupropion—CYP2E1—lymphoid tissue—colon cancer	0.000601	0.0173	CbGeAlD
Bupropion—CYP2E1—digestive system—colon cancer	0.000594	0.017	CbGeAlD
Bupropion—CYP3A4—renal system—colon cancer	0.000583	0.0167	CbGeAlD
Bupropion—CYP2D6—renal system—colon cancer	0.000573	0.0165	CbGeAlD
Bupropion—CYP2B6—vagina—colon cancer	0.000559	0.016	CbGeAlD
Bupropion—CYP2C8—liver—colon cancer	0.000526	0.0151	CbGeAlD
Bupropion—CYP1A2—liver—colon cancer	0.000492	0.0141	CbGeAlD
Bupropion—SLC6A2—lymph node—colon cancer	0.000491	0.0141	CbGeAlD
Bupropion—CYP3A4—digestive system—colon cancer	0.000478	0.0137	CbGeAlD
Bupropion—CYP2B6—liver—colon cancer	0.000471	0.0135	CbGeAlD
Bupropion—CYP2D6—digestive system—colon cancer	0.00047	0.0135	CbGeAlD
Bupropion—CYP2C9—liver—colon cancer	0.000467	0.0134	CbGeAlD
Bupropion—CYP2E1—liver—colon cancer	0.000442	0.0127	CbGeAlD
Bupropion—Nervous system disorder—Irinotecan—colon cancer	0.000404	0.00108	CcSEcCtD
Bupropion—Thrombocytopenia—Irinotecan—colon cancer	0.000403	0.00108	CcSEcCtD
Bupropion—Anorexia—Vincristine—colon cancer	0.000403	0.00108	CcSEcCtD
Bupropion—Irritability—Methotrexate—colon cancer	0.000398	0.00107	CcSEcCtD
Bupropion—Hyperhidrosis—Irinotecan—colon cancer	0.000398	0.00107	CcSEcCtD
Bupropion—Confusional state—Fluorouracil—colon cancer	0.000398	0.00107	CcSEcCtD
Bupropion—Mood swings—Methotrexate—colon cancer	0.000395	0.00106	CcSEcCtD
Bupropion—Hypotension—Vincristine—colon cancer	0.000395	0.00106	CcSEcCtD
Bupropion—Anaphylactic shock—Fluorouracil—colon cancer	0.000394	0.00106	CcSEcCtD
Bupropion—Oedema—Fluorouracil—colon cancer	0.000394	0.00106	CcSEcCtD
Bupropion—Anorexia—Irinotecan—colon cancer	0.000393	0.00105	CcSEcCtD
Bupropion—Ataxia—Methotrexate—colon cancer	0.000393	0.00105	CcSEcCtD
Bupropion—Infection—Fluorouracil—colon cancer	0.000392	0.00105	CcSEcCtD
Bupropion—Haemoglobin—Capecitabine—colon cancer	0.00039	0.00105	CcSEcCtD
Bupropion—Rhinitis—Capecitabine—colon cancer	0.000389	0.00104	CcSEcCtD
Bupropion—Hepatitis—Capecitabine—colon cancer	0.000388	0.00104	CcSEcCtD
Bupropion—Haemorrhage—Capecitabine—colon cancer	0.000388	0.00104	CcSEcCtD
Bupropion—Nervous system disorder—Fluorouracil—colon cancer	0.000387	0.00104	CcSEcCtD
Bupropion—Thrombocytopenia—Fluorouracil—colon cancer	0.000386	0.00104	CcSEcCtD
Bupropion—Hypoaesthesia—Capecitabine—colon cancer	0.000386	0.00103	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Vincristine—colon cancer	0.000385	0.00103	CcSEcCtD
Bupropion—Pharyngitis—Capecitabine—colon cancer	0.000385	0.00103	CcSEcCtD
Bupropion—Tachycardia—Fluorouracil—colon cancer	0.000385	0.00103	CcSEcCtD
Bupropion—Hypotension—Irinotecan—colon cancer	0.000385	0.00103	CcSEcCtD
Bupropion—Urinary tract disorder—Capecitabine—colon cancer	0.000383	0.00103	CcSEcCtD
Bupropion—Insomnia—Vincristine—colon cancer	0.000382	0.00103	CcSEcCtD
Bupropion—Oedema peripheral—Capecitabine—colon cancer	0.000382	0.00102	CcSEcCtD
Bupropion—Connective tissue disorder—Capecitabine—colon cancer	0.000381	0.00102	CcSEcCtD
Bupropion—Urethral disorder—Capecitabine—colon cancer	0.00038	0.00102	CcSEcCtD
Bupropion—Paraesthesia—Vincristine—colon cancer	0.00038	0.00102	CcSEcCtD
Bupropion—Breast disorder—Methotrexate—colon cancer	0.000377	0.00101	CcSEcCtD
Bupropion—Anorexia—Fluorouracil—colon cancer	0.000376	0.00101	CcSEcCtD
Bupropion—Visual impairment—Capecitabine—colon cancer	0.000374	0.001	CcSEcCtD
Bupropion—Insomnia—Irinotecan—colon cancer	0.000372	0.000999	CcSEcCtD
Bupropion—Paraesthesia—Irinotecan—colon cancer	0.00037	0.000991	CcSEcCtD
Bupropion—Hypotension—Fluorouracil—colon cancer	0.000369	0.000988	CcSEcCtD
Bupropion—Decreased appetite—Vincristine—colon cancer	0.000368	0.000986	CcSEcCtD
Bupropion—Dyspnoea—Irinotecan—colon cancer	0.000367	0.000984	CcSEcCtD
Bupropion—Erythema multiforme—Capecitabine—colon cancer	0.000367	0.000983	CcSEcCtD
Bupropion—Somnolence—Irinotecan—colon cancer	0.000366	0.000982	CcSEcCtD
Bupropion—Gastrointestinal disorder—Vincristine—colon cancer	0.000365	0.000979	CcSEcCtD
Bupropion—Fatigue—Vincristine—colon cancer	0.000365	0.000978	CcSEcCtD
Bupropion—Eye disorder—Capecitabine—colon cancer	0.000363	0.000972	CcSEcCtD
Bupropion—Dyspepsia—Irinotecan—colon cancer	0.000363	0.000972	CcSEcCtD
Bupropion—Tinnitus—Capecitabine—colon cancer	0.000362	0.00097	CcSEcCtD
Bupropion—Constipation—Vincristine—colon cancer	0.000362	0.00097	CcSEcCtD
Bupropion—Pain—Vincristine—colon cancer	0.000362	0.00097	CcSEcCtD
Bupropion—Asthma—Methotrexate—colon cancer	0.000361	0.000967	CcSEcCtD
Bupropion—Flushing—Capecitabine—colon cancer	0.00036	0.000965	CcSEcCtD
Bupropion—Cardiac disorder—Capecitabine—colon cancer	0.00036	0.000965	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000359	0.000963	CcSEcCtD
Bupropion—Decreased appetite—Irinotecan—colon cancer	0.000358	0.00096	CcSEcCtD
Bupropion—Insomnia—Fluorouracil—colon cancer	0.000357	0.000956	CcSEcCtD
Bupropion—CYP3A4—liver—colon cancer	0.000356	0.0102	CbGeAlD
Bupropion—Gastrointestinal disorder—Irinotecan—colon cancer	0.000356	0.000953	CcSEcCtD
Bupropion—Fatigue—Irinotecan—colon cancer	0.000355	0.000952	CcSEcCtD
Bupropion—Paraesthesia—Fluorouracil—colon cancer	0.000354	0.00095	CcSEcCtD
Bupropion—Pancreatitis—Methotrexate—colon cancer	0.000354	0.000948	CcSEcCtD
Bupropion—Constipation—Irinotecan—colon cancer	0.000352	0.000944	CcSEcCtD
Bupropion—Pain—Irinotecan—colon cancer	0.000352	0.000944	CcSEcCtD
Bupropion—Angiopathy—Capecitabine—colon cancer	0.000352	0.000944	CcSEcCtD
Bupropion—Dyspnoea—Fluorouracil—colon cancer	0.000352	0.000943	CcSEcCtD
Bupropion—Somnolence—Fluorouracil—colon cancer	0.000351	0.00094	CcSEcCtD
Bupropion—Immune system disorder—Capecitabine—colon cancer	0.00035	0.00094	CcSEcCtD
Bupropion—CYP2D6—liver—colon cancer	0.00035	0.0101	CbGeAlD
Bupropion—Mediastinal disorder—Capecitabine—colon cancer	0.00035	0.000937	CcSEcCtD
Bupropion—Chills—Capecitabine—colon cancer	0.000348	0.000933	CcSEcCtD
Bupropion—Dyspepsia—Fluorouracil—colon cancer	0.000347	0.000931	CcSEcCtD
Bupropion—Arrhythmia—Capecitabine—colon cancer	0.000347	0.000929	CcSEcCtD
Bupropion—Abdominal discomfort—Methotrexate—colon cancer	0.000346	0.000927	CcSEcCtD
Bupropion—Gastrointestinal pain—Vincristine—colon cancer	0.000346	0.000927	CcSEcCtD
Bupropion—Decreased appetite—Fluorouracil—colon cancer	0.000343	0.000919	CcSEcCtD
Bupropion—Alopecia—Capecitabine—colon cancer	0.000343	0.000919	CcSEcCtD
Bupropion—Pancytopenia—Methotrexate—colon cancer	0.000343	0.000919	CcSEcCtD
Bupropion—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000341	0.000913	CcSEcCtD
Bupropion—Mental disorder—Capecitabine—colon cancer	0.00034	0.000911	CcSEcCtD
Bupropion—Feeling abnormal—Irinotecan—colon cancer	0.000339	0.00091	CcSEcCtD
Bupropion—Malnutrition—Capecitabine—colon cancer	0.000338	0.000905	CcSEcCtD
Bupropion—Dysuria—Methotrexate—colon cancer	0.000337	0.000905	CcSEcCtD
Bupropion—Pain—Fluorouracil—colon cancer	0.000337	0.000904	CcSEcCtD
Bupropion—Gastrointestinal pain—Irinotecan—colon cancer	0.000337	0.000903	CcSEcCtD
Bupropion—Upper respiratory tract infection—Methotrexate—colon cancer	0.000335	0.000899	CcSEcCtD
Bupropion—Abdominal pain—Vincristine—colon cancer	0.000334	0.000896	CcSEcCtD
Bupropion—Body temperature increased—Vincristine—colon cancer	0.000334	0.000896	CcSEcCtD
Bupropion—Flatulence—Capecitabine—colon cancer	0.000333	0.000892	CcSEcCtD
Bupropion—Erectile dysfunction—Methotrexate—colon cancer	0.000332	0.000891	CcSEcCtD
Bupropion—Dysgeusia—Capecitabine—colon cancer	0.000331	0.000887	CcSEcCtD
Bupropion—Photosensitivity reaction—Methotrexate—colon cancer	0.000329	0.000883	CcSEcCtD
Bupropion—Back pain—Capecitabine—colon cancer	0.000327	0.000876	CcSEcCtD
Bupropion—Abdominal pain—Irinotecan—colon cancer	0.000326	0.000873	CcSEcCtD
Bupropion—Body temperature increased—Irinotecan—colon cancer	0.000326	0.000873	CcSEcCtD
Bupropion—Feeling abnormal—Fluorouracil—colon cancer	0.000325	0.000871	CcSEcCtD
Bupropion—Muscle spasms—Capecitabine—colon cancer	0.000325	0.000871	CcSEcCtD
Bupropion—Pneumonia—Methotrexate—colon cancer	0.000324	0.000868	CcSEcCtD
Bupropion—Infestation NOS—Methotrexate—colon cancer	0.000322	0.000863	CcSEcCtD
Bupropion—Infestation—Methotrexate—colon cancer	0.000322	0.000863	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000319	0.000855	CcSEcCtD
Bupropion—Vision blurred—Capecitabine—colon cancer	0.000318	0.000853	CcSEcCtD
Bupropion—Tremor—Capecitabine—colon cancer	0.000316	0.000848	CcSEcCtD
Bupropion—Stomatitis—Methotrexate—colon cancer	0.000314	0.000841	CcSEcCtD
Bupropion—Ill-defined disorder—Capecitabine—colon cancer	0.000313	0.00084	CcSEcCtD
Bupropion—Urticaria—Fluorouracil—colon cancer	0.000313	0.00084	CcSEcCtD
Bupropion—Conjunctivitis—Methotrexate—colon cancer	0.000313	0.000838	CcSEcCtD
Bupropion—Anaemia—Capecitabine—colon cancer	0.000312	0.000837	CcSEcCtD
Bupropion—Body temperature increased—Fluorouracil—colon cancer	0.000312	0.000836	CcSEcCtD
Bupropion—Hypersensitivity—Vincristine—colon cancer	0.000312	0.000835	CcSEcCtD
Bupropion—Sweating—Methotrexate—colon cancer	0.000308	0.000827	CcSEcCtD
Bupropion—Malaise—Capecitabine—colon cancer	0.000305	0.000817	CcSEcCtD
Bupropion—Epistaxis—Methotrexate—colon cancer	0.000303	0.000814	CcSEcCtD
Bupropion—Vertigo—Capecitabine—colon cancer	0.000303	0.000814	CcSEcCtD
Bupropion—Hypersensitivity—Irinotecan—colon cancer	0.000303	0.000814	CcSEcCtD
Bupropion—Asthenia—Vincristine—colon cancer	0.000303	0.000813	CcSEcCtD
Bupropion—Syncope—Capecitabine—colon cancer	0.000303	0.000812	CcSEcCtD
Bupropion—Leukopenia—Capecitabine—colon cancer	0.000302	0.000811	CcSEcCtD
Bupropion—Palpitations—Capecitabine—colon cancer	0.000298	0.0008	CcSEcCtD
Bupropion—Loss of consciousness—Capecitabine—colon cancer	0.000297	0.000796	CcSEcCtD
Bupropion—Asthenia—Irinotecan—colon cancer	0.000295	0.000792	CcSEcCtD
Bupropion—Cough—Capecitabine—colon cancer	0.000295	0.00079	CcSEcCtD
Bupropion—Hypertension—Capecitabine—colon cancer	0.000292	0.000782	CcSEcCtD
Bupropion—Hypersensitivity—Fluorouracil—colon cancer	0.000291	0.000779	CcSEcCtD
Bupropion—Haemoglobin—Methotrexate—colon cancer	0.00029	0.000778	CcSEcCtD
Bupropion—Diarrhoea—Vincristine—colon cancer	0.000289	0.000776	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—colon cancer	0.000289	0.000774	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—colon cancer	0.000289	0.000774	CcSEcCtD
Bupropion—Chest pain—Capecitabine—colon cancer	0.000288	0.000771	CcSEcCtD
Bupropion—Arthralgia—Capecitabine—colon cancer	0.000288	0.000771	CcSEcCtD
Bupropion—Myalgia—Capecitabine—colon cancer	0.000288	0.000771	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—colon cancer	0.000287	0.000769	CcSEcCtD
Bupropion—Anxiety—Capecitabine—colon cancer	0.000287	0.000768	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000286	0.000766	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—colon cancer	0.000285	0.000765	CcSEcCtD
Bupropion—Discomfort—Capecitabine—colon cancer	0.000284	0.000762	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—colon cancer	0.000283	0.000759	CcSEcCtD
Bupropion—Diarrhoea—Irinotecan—colon cancer	0.000282	0.000755	CcSEcCtD
Bupropion—Dry mouth—Capecitabine—colon cancer	0.000281	0.000754	CcSEcCtD
Bupropion—Dizziness—Vincristine—colon cancer	0.00028	0.00075	CcSEcCtD
Bupropion—Pruritus—Fluorouracil—colon cancer	0.000279	0.000748	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—colon cancer	0.000278	0.000746	CcSEcCtD
Bupropion—Confusional state—Capecitabine—colon cancer	0.000278	0.000745	CcSEcCtD
Bupropion—Oedema—Capecitabine—colon cancer	0.000276	0.000739	CcSEcCtD
Bupropion—Infection—Capecitabine—colon cancer	0.000274	0.000734	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—colon cancer	0.000273	0.000732	CcSEcCtD
Bupropion—Dizziness—Irinotecan—colon cancer	0.000272	0.00073	CcSEcCtD
Bupropion—Shock—Capecitabine—colon cancer	0.000271	0.000727	CcSEcCtD
Bupropion—Nervous system disorder—Capecitabine—colon cancer	0.00027	0.000725	CcSEcCtD
Bupropion—Eye disorder—Methotrexate—colon cancer	0.00027	0.000724	CcSEcCtD
Bupropion—Diarrhoea—Fluorouracil—colon cancer	0.00027	0.000724	CcSEcCtD
Bupropion—Thrombocytopenia—Capecitabine—colon cancer	0.00027	0.000724	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—colon cancer	0.000269	0.000722	CcSEcCtD
Bupropion—Tachycardia—Capecitabine—colon cancer	0.000269	0.000721	CcSEcCtD
Bupropion—Vomiting—Vincristine—colon cancer	0.000269	0.000721	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—colon cancer	0.000268	0.000719	CcSEcCtD
Bupropion—Skin disorder—Capecitabine—colon cancer	0.000268	0.000718	CcSEcCtD
Bupropion—Rash—Vincristine—colon cancer	0.000267	0.000715	CcSEcCtD
Bupropion—Hyperhidrosis—Capecitabine—colon cancer	0.000266	0.000714	CcSEcCtD
Bupropion—Dermatitis—Vincristine—colon cancer	0.000266	0.000714	CcSEcCtD
Bupropion—Headache—Vincristine—colon cancer	0.000265	0.00071	CcSEcCtD
Bupropion—Anorexia—Capecitabine—colon cancer	0.000263	0.000704	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—colon cancer	0.000262	0.000703	CcSEcCtD
Bupropion—Vomiting—Irinotecan—colon cancer	0.000262	0.000702	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—colon cancer	0.000261	0.000699	CcSEcCtD
Bupropion—Dizziness—Fluorouracil—colon cancer	0.000261	0.000699	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—colon cancer	0.00026	0.000698	CcSEcCtD
Bupropion—Rash—Irinotecan—colon cancer	0.00026	0.000696	CcSEcCtD
Bupropion—Dermatitis—Irinotecan—colon cancer	0.000259	0.000696	CcSEcCtD
Bupropion—Chills—Methotrexate—colon cancer	0.000259	0.000695	CcSEcCtD
Bupropion—Headache—Irinotecan—colon cancer	0.000258	0.000692	CcSEcCtD
Bupropion—Hypotension—Capecitabine—colon cancer	0.000258	0.000691	CcSEcCtD
Bupropion—Alopecia—Methotrexate—colon cancer	0.000255	0.000684	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—colon cancer	0.000253	0.000678	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—colon cancer	0.000251	0.000674	CcSEcCtD
Bupropion—Nausea—Vincristine—colon cancer	0.000251	0.000673	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000251	0.000673	CcSEcCtD
Bupropion—Vomiting—Fluorouracil—colon cancer	0.000251	0.000672	CcSEcCtD
Bupropion—Insomnia—Capecitabine—colon cancer	0.000249	0.000668	CcSEcCtD
Bupropion—Rash—Fluorouracil—colon cancer	0.000249	0.000667	CcSEcCtD
Bupropion—Dermatitis—Fluorouracil—colon cancer	0.000248	0.000666	CcSEcCtD
Bupropion—Paraesthesia—Capecitabine—colon cancer	0.000247	0.000664	CcSEcCtD
Bupropion—Headache—Fluorouracil—colon cancer	0.000247	0.000663	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—colon cancer	0.000246	0.00066	CcSEcCtD
Bupropion—Dyspnoea—Capecitabine—colon cancer	0.000246	0.000659	CcSEcCtD
Bupropion—Nausea—Irinotecan—colon cancer	0.000245	0.000656	CcSEcCtD
Bupropion—Back pain—Methotrexate—colon cancer	0.000243	0.000652	CcSEcCtD
Bupropion—Dyspepsia—Capecitabine—colon cancer	0.000243	0.000651	CcSEcCtD
Bupropion—Decreased appetite—Capecitabine—colon cancer	0.00024	0.000642	CcSEcCtD
Bupropion—Gastrointestinal disorder—Capecitabine—colon cancer	0.000238	0.000638	CcSEcCtD
Bupropion—Fatigue—Capecitabine—colon cancer	0.000238	0.000637	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—colon cancer	0.000237	0.000635	CcSEcCtD
Bupropion—Pain—Capecitabine—colon cancer	0.000236	0.000632	CcSEcCtD
Bupropion—Constipation—Capecitabine—colon cancer	0.000236	0.000632	CcSEcCtD
Bupropion—Nausea—Fluorouracil—colon cancer	0.000234	0.000628	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—colon cancer	0.000233	0.000625	CcSEcCtD
Bupropion—Anaemia—Methotrexate—colon cancer	0.000232	0.000623	CcSEcCtD
Bupropion—Feeling abnormal—Capecitabine—colon cancer	0.000227	0.000609	CcSEcCtD
Bupropion—Malaise—Methotrexate—colon cancer	0.000227	0.000608	CcSEcCtD
Bupropion—Vertigo—Methotrexate—colon cancer	0.000226	0.000606	CcSEcCtD
Bupropion—Gastrointestinal pain—Capecitabine—colon cancer	0.000225	0.000604	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—colon cancer	0.000225	0.000603	CcSEcCtD
Bupropion—Cough—Methotrexate—colon cancer	0.000219	0.000588	CcSEcCtD
Bupropion—Urticaria—Capecitabine—colon cancer	0.000219	0.000587	CcSEcCtD
Bupropion—Body temperature increased—Capecitabine—colon cancer	0.000218	0.000584	CcSEcCtD
Bupropion—Abdominal pain—Capecitabine—colon cancer	0.000218	0.000584	CcSEcCtD
Bupropion—Convulsion—Methotrexate—colon cancer	0.000218	0.000584	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—colon cancer	0.000214	0.000574	CcSEcCtD
Bupropion—Chest pain—Methotrexate—colon cancer	0.000214	0.000574	CcSEcCtD
Bupropion—Myalgia—Methotrexate—colon cancer	0.000214	0.000574	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000213	0.00057	CcSEcCtD
Bupropion—Discomfort—Methotrexate—colon cancer	0.000211	0.000567	CcSEcCtD
Bupropion—Confusional state—Methotrexate—colon cancer	0.000207	0.000555	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—colon cancer	0.000205	0.00055	CcSEcCtD
Bupropion—Infection—Methotrexate—colon cancer	0.000204	0.000547	CcSEcCtD
Bupropion—Hypersensitivity—Capecitabine—colon cancer	0.000203	0.000544	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—colon cancer	0.000201	0.00054	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—colon cancer	0.000201	0.000539	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—colon cancer	0.000199	0.000534	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—colon cancer	0.000198	0.000532	CcSEcCtD
Bupropion—Asthenia—Capecitabine—colon cancer	0.000198	0.00053	CcSEcCtD
Bupropion—Anorexia—Methotrexate—colon cancer	0.000196	0.000524	CcSEcCtD
Bupropion—Pruritus—Capecitabine—colon cancer	0.000195	0.000523	CcSEcCtD
Bupropion—Hypotension—Methotrexate—colon cancer	0.000192	0.000514	CcSEcCtD
Bupropion—Diarrhoea—Capecitabine—colon cancer	0.000189	0.000506	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000187	0.000501	CcSEcCtD
Bupropion—Insomnia—Methotrexate—colon cancer	0.000186	0.000498	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—colon cancer	0.000184	0.000494	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—colon cancer	0.000183	0.00049	CcSEcCtD
Bupropion—Somnolence—Methotrexate—colon cancer	0.000182	0.000489	CcSEcCtD
Bupropion—Dizziness—Capecitabine—colon cancer	0.000182	0.000489	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—colon cancer	0.000181	0.000484	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—colon cancer	0.000178	0.000478	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—colon cancer	0.000177	0.000475	CcSEcCtD
Bupropion—Fatigue—Methotrexate—colon cancer	0.000177	0.000474	CcSEcCtD
Bupropion—Pain—Methotrexate—colon cancer	0.000175	0.00047	CcSEcCtD
Bupropion—Vomiting—Capecitabine—colon cancer	0.000175	0.00047	CcSEcCtD
Bupropion—Rash—Capecitabine—colon cancer	0.000174	0.000466	CcSEcCtD
Bupropion—Dermatitis—Capecitabine—colon cancer	0.000174	0.000466	CcSEcCtD
Bupropion—Headache—Capecitabine—colon cancer	0.000173	0.000463	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—colon cancer	0.000169	0.000453	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—colon cancer	0.000168	0.00045	CcSEcCtD
Bupropion—Nausea—Capecitabine—colon cancer	0.000164	0.000439	CcSEcCtD
Bupropion—Urticaria—Methotrexate—colon cancer	0.000163	0.000437	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—colon cancer	0.000162	0.000435	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—colon cancer	0.000162	0.000435	CcSEcCtD
Bupropion—Hypersensitivity—Methotrexate—colon cancer	0.000151	0.000405	CcSEcCtD
Bupropion—Asthenia—Methotrexate—colon cancer	0.000147	0.000395	CcSEcCtD
Bupropion—Pruritus—Methotrexate—colon cancer	0.000145	0.000389	CcSEcCtD
Bupropion—Diarrhoea—Methotrexate—colon cancer	0.00014	0.000376	CcSEcCtD
Bupropion—Dizziness—Methotrexate—colon cancer	0.000136	0.000364	CcSEcCtD
Bupropion—Vomiting—Methotrexate—colon cancer	0.00013	0.00035	CcSEcCtD
Bupropion—Rash—Methotrexate—colon cancer	0.000129	0.000347	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—colon cancer	0.000129	0.000347	CcSEcCtD
Bupropion—Headache—Methotrexate—colon cancer	0.000129	0.000345	CcSEcCtD
Bupropion—Nausea—Methotrexate—colon cancer	0.000122	0.000327	CcSEcCtD
